Capital International, Inc. Agios Pharmaceuticals, Inc. Transaction History

Capital International, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $3.28 Million - $4.6 Million	-98,882 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$33.87 - $55.93 $25,233 - $41,667	745 Added 0.76%	98,882 $3.46 Million
Q2 2020 Aug 14, 2020	BUY	$34.45 - $53.48 $1.09 Million - $1.7 Million	31,758 Added 47.84%	98,137 $5.25 Million
Q1 2020 May 15, 2020	BUY	$31.52 - $53.81 $87,688 - $149,699	2,782 Added 4.37%	66,379 $2.36 Million
Q4 2019 Feb 18, 2020	SELL	$30.08 - $50.59 $9.07 Million - $15.3 Million	-301,541 Reduced 82.58%	63,597 $3.04 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $10.3 Million - $15.7 Million	316,861 Added 656.34%	365,138 $11.8 Million
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $1.29 Million - $1.9 Million	27,901 Added 136.93%	48,277 $2.41 Million
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $45,920 - $67,670	-1,000 Reduced 4.68%	20,376 $1.37 Million
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $435,466 - $558,688	6,076 Added 39.71%	21,376 $1.65 Million
Q2 2018 Aug 14, 2018	SELL	$73.22 - $99.55 $65,898 - $89,595	-900 Reduced 5.56%	15,300 $1.29 Million
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $679,070 - $982,115	-11,350 Reduced 41.2%	16,200 $1.33 Million
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $690,590 - $958,372	-13,250 Reduced 32.48%	27,550 $1.58 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $2.24 Million - $2.74 Million	40,800	40,800 $2.72 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.